RHM has dropped 23% in a month and 15% in a week alone, yet the company's own CEO has spent roughly $14 million buying shares in the past six weeks. That divergence — a stock in freefall, insiders loading up — is the story heading into Thursday's earnings release.
The insider signal is hard to ignore. CEO Armin Papperger has made five separate purchases since late May, accumulating more than 11,000 shares at prices ranging from roughly €954 to €1,405. The largest single transaction, on June 1, was worth over $5.8 million. The Supervisory Board Chairman and COO have also bought. In total, insiders have net-purchased nearly 12,000 shares worth approximately $15.7 million over the past 90 days — all buys, no offsetting sales. This is concentrated, consistent, and personal-capital buying from the people who know the business best.
The lending market offers no signal that short sellers are pressing the move lower. Borrow availability is extraordinarily loose — availability has actually risen sharply this week to around 5,800% relative to shares already borrowed, well above the 52-week floor of roughly 1,475%. With only 1.8% of available shares currently lent out, and cost to borrow sitting at a modest 0.56%, there is no evidence of a meaningful short-side pile-on. The short score at 29.4 is low and has been drifting slightly higher over the past week but remains far below distress levels. The lending picture looks indifferent rather than aggressive.
The Street's read is firmly constructive, though the price action is making that case harder to hold. The analyst consensus mean price target is €1,766 — nearly 80% above Tuesday's close of €990.50. That gap is striking. The forward earnings story supports some of that optimism: the EPS 12-month forward year-on-year growth factor ranks in the 89th percentile of the ORTEX universe, and EPS momentum over the past 30 days ranks at the 78th percentile. But quality metrics have deteriorated sharply. The Piotroski F-score has collapsed from 7 to 1 this year, return on assets has nearly halved, and EV/EBIT has pushed into stretched territory. The PE multiple, at 26.4x, has compressed with the price but remains elevated relative to defense peers. The short score rank at the 72nd percentile — meaning RHM scores better than most on short-side risk — also reflects limited short pressure rather than speculative demand.
The peer comparison makes RHM's weekly drop stand out. SAAB B fell less than 1% on the week. LDO dropped 7% and BAB fell 5%, so some sector-wide pressure is real. But BA. actually gained 1% on the week. RHM's 15% weekly drawdown is roughly double the move of even its weakest peers, suggesting stock-specific factors — most likely earnings anxiety — are amplifying the sector rotation.
The recent earnings record adds context to that anxiety. The last print, on May 7, saw the stock fall 15% on the day and nearly 21% over the following week. The May 12 release saw a 5% drop. Going back through the available history, the post-earnings pattern for RHM has been consistently negative on the day. With Q1 results landing tomorrow after the close of European trading, how management addresses the gap between the €1,766 analyst consensus target and a stock trading below €1,000 — and whether the forward guidance supports the exceptional growth implied by those EPS momentum rankings — will determine whether the CEO's sustained buying was well-timed or premature.
See the live data behind this article on ORTEX.
Open RHM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
